These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1900425)

  • 1. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma.
    Rose RM; Fuglestad JM; Remington L
    Am J Respir Cell Mol Biol; 1991 Mar; 4(3):248-54. PubMed ID: 1900425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes.
    Shiratsuchi H; Johnson JL; Ellner JJ
    J Immunol; 1991 May; 146(9):3165-70. PubMed ID: 1901893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Leukoc Biol; 1990 Jul; 48(1):67-73. PubMed ID: 2113563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.
    Suzuki K; Lee WJ; Hashimoto T; Tanaka E; Murayama T; Amitani R; Yamamoto K; Kuze F
    Clin Exp Immunol; 1994 Oct; 98(1):169-73. PubMed ID: 7923877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective T cell function for inhibition of growth of Mycobacterium avium-intracellulare complex (MAC) in patients with MAC disease: restoration by cytokines.
    Tsukaguchi K; Yoneda T; Okamura H; Tamaki S; Takenaka H; Okamoto Y; Narita N
    J Infect Dis; 2000 Dec; 182(6):1664-71. PubMed ID: 11069238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
    Bermudez LE
    J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
    Vairo G; Royston AK; Hamilton JA
    J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo.
    Kedzierska K; Mak J; Mijch A; Cooke I; Rainbird M; Roberts S; Paukovics G; Jolley D; Lopez A; Crowe SM
    J Infect Dis; 2000 Jan; 181(1):390-4. PubMed ID: 10608795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.
    de Silva TI; Cope A; Goepel J; Greig JM
    J Infect; 2007 Apr; 54(4):e207-10. PubMed ID: 17197031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro.
    Reardon CC; Kim SJ; Wagner RP; Kornfeld H
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):711-5. PubMed ID: 8969264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cytokines on anti-Mycobacterium avium complex (MAC) activities of human alveolar macrophages].
    Suzuki K; Yamamoto T; Yuba Y; Sato A; Kubo Y; Murayama T; Kuze F
    Kekkaku; 1992 Jan; 67(1):63-9. PubMed ID: 1542209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects.
    Denis M; Ghadirian E
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):487-95. PubMed ID: 7917317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.
    Denis M; Gregg EO
    Immunology; 1990 Sep; 71(1):139-41. PubMed ID: 2120128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
    Lu L; Welte K; Gabrilove JL; Hangoc G; Bruno E; Hoffman R; Broxmeyer HE
    Cancer Res; 1986 Sep; 46(9):4357-61. PubMed ID: 3089590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
    Thomassen MJ; Barna BP; Wiedemann HP; Ahmad M
    J Biol Response Mod; 1990 Feb; 9(1):87-91. PubMed ID: 2156955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro.
    Nakata K; Akagawa KS; Fukayama M; Hayashi Y; Kadokura M; Tokunaga T
    J Immunol; 1991 Aug; 147(4):1266-72. PubMed ID: 1869822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.